Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer
Abstract Background Ovarian cancer is the most lethal gynaecological malignancy. Chemotherapy is the main stay of treatment for metastatic disease, with modest response rates but significant side effects. Therefore, there is a need for alternative therapies that can control the disease while offerin...
Autors principals: | Karen K. L. Chan, Michelle K. Y. Siu, Yu-xin Jiang, Jing-jing Wang, Thomas H. Y. Leung, Hextan Y. S. Ngan |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
BMC
2018-05-01
|
Col·lecció: | Cancer Cell International |
Matèries: | |
Accés en línia: | http://link.springer.com/article/10.1186/s12935-018-0559-2 |
Ítems similars
-
The Impacts of Genistein and Daidzein on Estrogen Conjugations in Human Breast Cancer Cells: A Targeted Metabolomics Approach
per: Stefan Poschner, et al.
Publicat: (2017-10-01) -
Effects of soy isoflavonoids (genistein and daidzein) on endometrial receptivity
per: Erdem Toktay, et al.
Publicat: (2020-12-01) -
Development and validation of PBPK models for genistein and daidzein for use in a next-generation risk assessment
per: A. Najjar, et al.
Publicat: (2024-10-01) -
Quantification of genistein and daidzein in two endemic Genista species and their antioxidant activity
per: ILKAY ERDOGAN ORHAN, et al.
Publicat: (2011-01-01) -
Production of isoflavones, daidzein and genistein in callus cultures of Pueraria candollei Wall. ex Benth. var. mirifica
per: Sanha Panichajakul, et al.
Publicat: (2006-03-01)